BDPT Stock Chart & Stats
$0.01
>-$0.01(-1.48%)
At close: 4:00 PM EDT
$0.01
>-$0.01(-1.48%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.09
Previous CloseN/A
Volume1.77M
Average Volume (3M)12.25K
Market Cap
$224.50K
Enterprise Value$418.80K
Total Cash (Recent Filing)$29.22K
Total Debt (Recent Filing)$522.73K
Price to Earnings (P/E)―
Beta-0.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding196,926,760
10 Day Avg. Volume6,637
30 Day Avg. Volume12,246
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.10
Price to Sales (P/S)12.18
P/FCF Ratio-0.42
Enterprise Value/Market Cap1.87
Enterprise Value/Revenue16.38
Enterprise Value/Gross Profit22.00
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BDPT FAQ
What was BioAdaptives’s price range in the past 12 months?
BioAdaptives lowest stock price was <$0.01 and its highest was $0.09 in the past 12 months.
What is BioAdaptives’s market cap?
BioAdaptives’s market cap is $224.50K.
When is BioAdaptives’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioAdaptives’s earnings last quarter?
Currently, no data Available
Is BioAdaptives overvalued?
According to Wall Street analysts BioAdaptives’s price is currently Overvalued.
Does BioAdaptives pay dividends?
BioAdaptives does not currently pay dividends.
What is BioAdaptives’s EPS estimate?
BioAdaptives’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioAdaptives have?
BioAdaptives has 196,926,760 shares outstanding.
What happened to BioAdaptives’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioAdaptives?
Currently, no hedge funds are holding shares in BDPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioAdaptives
BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.
Technical Analysis
Natural Alternatives International
―
Nature's Sunshine Products
―
USANA Health
―
FitLife Brands
―
Healthy Choice Wellness Corp. Class A
―